14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Neuralgia in 2 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
Neuralgia: Intense or aching pain that occurs along the course or distribution of a peripheral or cranial nerve.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, T | 2 |
| Li, T | 1 |
| Chen, X | 2 |
| Li, Z | 2 |
| Feng, M | 1 |
| Yao, W | 2 |
| Wan, L | 2 |
| Zhang, C | 2 |
| Zhang, Y | 2 |
| Zhang, B | 1 |
2 other studies available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Neuralgia
| Article | Year |
|---|---|
EETs/sEHi alleviates nociception by blocking the crosslink between endoplasmic reticulum stress and neuroinflammation in a central poststroke pain model.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Endoplasmic Reticulum Stress; Epoxide Hydrolases; Male; Neural | 2021 |
Antinociception role of 14,15-epoxyeicosatrienoic acid in a central post-stroke pain model in rats mediated by anti-inflammation and anti-apoptosis effect.
Topics: 8,11,14-Eicosatrienoic Acid; Animals; Anti-Inflammatory Agents; Neuralgia; Rats; Rats, Sprague-Dawle | 2022 |